[Use of 5-butyl-1-cyclohexyl-2,4,6,-trioxoperidropyrimidine (BCP) in the prevention and therapy of neonatal hyperbilirubinemia. Comparative study with phenobarbital].

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples